Liquidia (NASDAQ:LQDA) Stock Rating Upgraded by Wall Street Zen

Liquidia (NASDAQ:LQDA) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Sunday, Wall Street Zen reports.

Other research analysts have also recently issued research reports about the company. Bank of America increased their target price on Liquidia from $79.00 to $92.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th. Royal Bank Of Canada set a $130.00 price target on Liquidia in a research note on Friday, July 24th. Zacks Research cut Liquidia from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 13th. Wells Fargo & Company increased their price objective on Liquidia from $62.00 to $108.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th. Finally, Lifesci Capital cut Liquidia from an “outperform” rating to a “hold” rating and set a $90.00 price objective on the stock. in a report on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $98.08.

Liquidia Trading Down 0.7%

Shares of Liquidia stock opened at $66.43 on Friday. Liquidia has a 1 year low of $21.15 and a 1 year high of $93.61. The firm has a market cap of $5.95 billion, a PE ratio of 48.49 and a beta of 0.53. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. The company has a 50 day simple moving average of $76.08 and a two-hundred day simple moving average of $60.95.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The company had revenue of $171.68 million during the quarter, compared to the consensus estimate of $168.48 million. Liquidia had a return on equity of 149.65% and a net margin of 30.74%.Liquidia’s quarterly revenue was up 1842.1% on a year-over-year basis. During the same period in the previous year, the company earned ($0.49) EPS. Analysts expect that Liquidia will post 2.57 earnings per share for the current fiscal year.

Insider Transactions at Liquidia

In related news, Director Raman Singh sold 8,468 shares of Liquidia stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $66.16, for a total transaction of $560,242.88. Following the sale, the director directly owned 44,637 shares in the company, valued at $2,953,183.92. The trade was a 15.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Rajeev Saggar sold 50,000 shares of the firm’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $74.06, for a total value of $3,703,000.00. Following the transaction, the insider directly owned 142,265 shares of the company’s stock, valued at $10,536,145.90. This represents a 26.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 622,519 shares of company stock worth $48,078,514. Corporate insiders own 25.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Covestor Ltd increased its position in shares of Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after purchasing an additional 359 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Liquidia by 7.2% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock worth $217,000 after buying an additional 422 shares during the last quarter. Quantinno Capital Management LP grew its position in Liquidia by 3.6% during the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock valued at $648,000 after buying an additional 589 shares during the period. ProShare Advisors LLC grew its position in Liquidia by 7.1% during the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after buying an additional 775 shares during the period. Finally, Arizona State Retirement System increased its holdings in Liquidia by 5.4% during the second quarter. Arizona State Retirement System now owns 17,627 shares of the company’s stock valued at $1,405,000 after buying an additional 900 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors.

Liquidia Company Profile

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious cardiopulmonary conditions, including pulmonary arterial hypertension (PAH). The company is headquartered in Research Triangle Park, North Carolina, and serves healthcare providers and patients primarily in the United States.

Liquidia’s lead product is Yutrepia, an inhaled formulation of treprostinil designed for the treatment of PAH. The company has also developed treprostinil injection products and is pursuing additional therapies for rare cardiopulmonary diseases.